CXCL10 and infection: To assess the impact of the production of IP-10 on the reduced viral titer detected in A549 WT cells, absent in FFAR2 deficient cells, we repeated the same experimental set-up with infection in combination with acetate treatment on IP-10 deficient cells (IP-10-KO).